Stock Events

Stock Events

Galectin Therapeutics (GALT) Q1 2026 Earnings

31MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.2

-0.16

-0.12

-0.08

Details

Expected EPS

-0.1

Actual EPS

-0.08

Surprise EPS

0.02

Surprise Percent

+20%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.08 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.